OSI Pharmaceuticals Foundation Awards Grant to Dolan DNA Learning Center
(from l-r): David Micklos (DNALC Executive Director), James D. Watson (CSHL Chancellor), Ann McDermott-Kave (Director of the OSI Pharmaceuticals Foundation), Colin Goddard (OSI Pharmaceuticals Chief Executive Officer) and G. Morgan Browne (Chairman of the OSI Pharmaceuticals Foundation).
Cold Spring Harbor Laboratory’s Dolan DNA Learning Center received an initial $50,000 payment towards a $200,000 pledge from the newly-established OSI Pharmaceuticals Foundation to build and support the DNALC endowment.
The OSI Pharmaceuticals Foundation was established in 2005 with the purpose of promoting community involvement through support of charitable organizations and initiatives focused on scienti€c and medical research, science education and on patient supportive care. OSI Pharmaceuticals is committed to “shaping medicines and changing lives” by discovering, developing and commercializing high quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, eye diseases and diabetes. For more information, visit www.osip.com
The Dolan DNA Learning Center – an operating arm of Cold Spring Harbor Laboratory – prepares students and families to thrive in the gene age by providing 5th through 12th graders with hands-on laboratory experiences and offering them educational opportunities that are unavailable in their own schools. Each year, nearly 40,000 students and teachers from Long Island, all five boroughs of New York City, and around the country benefit from the labs, lectures, field trips and workshops provided by the Center's teaching staff. The DNALC’s Internet portal, Gene Almanac (www.genealmanac.org), and family of content sites (DNA from the Beginning; DNA Interactive; Genetic Origins; Inside Cancer; Your Genes, Your Health and others) received 6.15 million visitors in 2005. For more information, visit www.dnalc.org.
For more information, visit www.cshl.edu.